Zexiong Guo
- Molecular Biology top 10%
- Biomaterials top 2%
- Oncology top 10%
- Biomedical Engineering
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Daryl C. DrummondCharles O. NobleDmitri B. KirpotinJohn W. ParkKeelung HongChristopher C. BenzGary K. ScottChristoph Mamot
- Topics
- Nanoparticle-Based Drug Delivery (6 papers)Lung Cancer Research Studies (3 papers)Cancer therapeutics and mechanisms (3 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Zexiong Guo
15 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 958
- Biomaterials 487
- Oncology 344
- Biomedical Engineering 234
- Radiology, Nuclear Medicine and Imaging 133
Countries citing papers authored by Zexiong Guo
This map shows the geographic impact of Zexiong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zexiong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zexiong Guo more than expected).
Fields of papers citing papers by Zexiong Guo
This network shows the impact of papers produced by Zexiong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zexiong Guo. The network helps show where Zexiong Guo may publish in the future.
Co-authorship network of co-authors of Zexiong Guo
This figure shows the co-authorship network connecting the top 25 collaborators of Zexiong Guo. A scholar is included among the top collaborators of Zexiong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zexiong Guo. Zexiong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 7 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 17 | |
| 6 | 4 | |
| 7 | 87 | |
| 8 | 57 | |
| 9 | 41 | |
| 10 | 301 | |
| 11 | 45 | |
| 12 | Development of novel liposomal and receptor tyrosine kinase-targeted immunoliposomal vinorelbine formulations with improved drug retention | 2 |
| 13 | Development of a highly stable liposomal irinotecan with low toxicity and potent antitumor efficacy | 1 |
| 14 | 297 | |
| 15 | 496 |
About Zexiong Guo
Zexiong Guo is a scholar working on Biomaterials, Transplantation and Oncology, having authored 15 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Lung Cancer Research Studies (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Biomaterials (487 citations), Molecular Biology (958 citations) and Oncology (344 citations). Zexiong Guo has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Daryl C. Drummond, Charles O. Noble, Dmitri B. Kirpotin, John W. Park, Keelung Hong, Christopher C. Benz, Gary K. Scott, Christoph Mamot, Mark Hayes and Byron Hann. Their work appears in journals such as Advanced Functional Materials, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.